Results 121 to 130 of about 2,541 (157)

An aptamer-conjugated mesoporous polydopamine formulation for synergistic targeted and photothermal therapy of hepatocellular carcinoma. [PDF]

Int J Pharm X
Yang Y, Wang C, Liu S, Zhang Y.
europepmc   +1 more source

Nucleolin-Targeted DNA Nanoflowers Enable Multimodal Synergistic Cancer Therapy. [PDF]

Biomater Res
Ren A, Liu H, Tang Z, Zheng P, Hu Q, Huang T.   +5 more
europepmc   +1 more source

Aptamer as a therapeutic agent for dengue infections. [PDF]

Virol J
Mislan NAL, Marimuthu C, Akmal Shukri AM, Suppiah J, Mohd Zain R, Mohd Nor F, Wang SM.   +6 more
europepmc   +1 more source

Comparative Analysis of Aptamer-Conjugated Chemical and Green Synthesized Gold Nanoparticles for Targeted Therapy in MCF-7 Cancer Cells. [PDF]

Appl Biochem Biotechnol
Helal MW, Faried MM, Salah SM, Ashraf M, Nasser N, Shawky Y, Hamdy S, Amir AE, Nabil W, El-Husseini DM.   +9 more
europepmc   +1 more source

Click-constructed modular signal aptamer chimeras enable receptor-independent degradation of membrane proteins. [PDF]

Proc Natl Acad Sci U S A
Xie W, Sun W, Li Q, Dang Y, Ma L, Liu Y, Zhang H, Qu F, Tan W.   +8 more
europepmc   +1 more source

Surface-Modified Nanozymes for Enhanced and Selective Catalysis. [PDF]

ACS Appl Mater Interfaces
Chen X, Willner I.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapeutic applications of AS1411 aptamer, an update review

International Journal of Biological Macromolecules, 2020
Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus. However, in several cancers, nucleolin is highly expressed both intracellularly and on the cell surface. So, it is considered as a potential target for the diagnosis and cancer therapy.
Mohammad Ramezani, Khalil Abnous, Rezvan Yazdian- Robati   +2 more
exaly   +3 more sources

Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411

Experimental Eye Research, 2020
Corneal neovascularization (CNV) is a common sight-threatening pathology that can be induced by a variety of inflammatory and angiogenic stimuli. Current CNV treatments include anti-inflammatory drugs and antibody-based inhibitors of vascular endothelial growth factor (VEGF).
OSCAR Vivanco-Rojas, Armando Pérez-Torres, Yonathan Garfias   +2 more
exaly   +3 more sources

Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411 [PDF]

Cancer Investigation, 2018
AS1411 is an antiproliferative DNA aptamer, which binds the ubiquitous protein, nucleolin. In this study, we show that constitutive overexpression of nucleolin confers increased sensitivity to the growth inhibitory effects of AS1411. HeLa cells overexpressing nucleolin have an increased growth rate and invasiveness relative to control cells.
Shelia Thomas, Francine Rezzoug, Donald Miller   +2 more
exaly   +3 more sources